Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Our Chairman Stephen Parker will be attending the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, from 9-12 January.
At Sareum Ltd we are focused on advancing our internal programmes on distinct dual tyrosine kinase 2 (#TYK2) / Janus kinase 1 (#JAK1) inhibitors into clinical development as potential new therapies for autoimmune diseases, respiratory symptoms arising from viral infections and cancer immunotherapy.
Stephen would be delighted to meet anyone who would like to learn more about Sareum, so please get in contact if you would like to meet with him.
#JPM2023 #Conference #Healthcare
Gropelad you wished ha ha it was .. 30 ish when you ramped boil. As if anyone listen to a prover porkie teller.
“The unexpected bonus is getting out for a while and picking up some baron oil (boil) recoup losses. Big announcement on or before 26th”
You said that on the 20th a look what happen. Your locked in there and here great bit of trading that lad Lol.
Taken from the latest Edison report..
“ The magnitude of the issue and what exactly the MHRA observations relate to is unclear. Sareum is in talks with the MHRA to seek further information and will be updating the market on subsequent developments. The company had planned to initiate the Phase Ia trial (safety and dose-finding study in healthy volunteers) in Q422 which, in our opinion, is now likely to be delayed until 2023 at the earliest.”
It seems everyone is in The dark.
Not sure if this has been posted
https://www.edisongroup.com/edison-open-house-global-healthcare-2022/
Wart
"Slow and steady wins the race"
Hmmmmmm plenty of opportunities to bail out with a tidy profit over the past few years, as many have. Can’t see how any LTH is locked in, unless your frightened you might miss something.
GLA
Not long now to the AGM announcement, any Qs or concerns can then be put to the BoD. There’s only 60ish days left of this 4qtr mentioned so they must be ready to start or they would have announced the delay today.
GLA
I’m wondering if the BOD were expecting the hand back from GSK, do they also feel deflated like some Investors in here? After this “mild setback” nothing has changed re the plan laid out last year. It’s still on track with no setbacks. It’s going to be an interesting end to the year. GLA